However, the potential role of ERBB2 in the development of metastatic prostate cancer is unclear partly because various attempts to assess frequencies of ERBB2 amplification/overexpression in human prostate cancer samples yielded inconsistent results [16]–[25]. This evidence concerns the gene ERBB2 and prostate carcinoma.